Loading
Loading…
Loading…
Tender Value
₹88,631.05
EMD Value
Exempted
Closing Date
2 Sept 2026, 11:00 am5d left
PROCUREMENT OF MEDICAL STORES
9781312
GEM/2026/B/7939669
Two Packet Bid
Amoxicillin 875 mg plus Clavulanic Acid 125 mg Tab,Baclofen XL 30 mg Tab,Sacubitril 49 mg plus Vals
The Nilgiris, Tamil Nadu
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹31
₹3 L
70%
Commandant, MH Wellington, Department of Military Affairs, Indian Army, Ministry of Defence, (Rajiv Kumar)
Exempted
Yes
22 Aug 2026
22 Aug 2026
2 Sept 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Amoxicillin 875 mg plus Clavulanic Acid 125 mg Tab | 2,000 | No | NILGIRIS | 30 |
| 2 | Baclofen XL 30 mg Tab | 210 | No | NILGIRIS | 30 |
| 3 | Sacubitril 49 mg plus Valsartan 51 mg Tab | 600 | No | NILGIRIS | 30 |
| 4 | Cabergoline 0 point5 mg Tab | 60 | No | NILGIRIS | 30 |
| 5 | Ciprofloxacin 250 mg plusTinidazole 300 mg | 200 | No | NILGIRIS | 30 |
| 6 | Levetiracetam 500 mg Tab | 2,500 | No | NILGIRIS | 30 |
| 7 | Povidone Iodine 200 mg Vaginal Pessary | 150 | No | NILGIRIS | 30 |
| 8 | Montelukast 10 mg plus Levocetirizine 5 mg Tab | 4,000 | No | NILGIRIS | 30 |
| 9 | Tab Dicyclomine 20 mg | 480 | No | NILGIRIS | 30 |
| 10 | Methylcobalamine 1500 mcg Tab | 3,900 | No | NILGIRIS | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9781312.pdf
GEM_BID • 0.42 MB
docscanner_20-aug-2026_10-40_am_2026-08-20-10-47-19_92d6f09fed944d10cf603bf66206f1f5.pdf
BOQ • 1.28 MB
boq_item_sample_file_-1_2026-08-20-10-47-19_eaf208d40914ebd632610972d661e611.csv
BOQ • 0.01 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].